STAT3 and central nervous system cancer: Our previous data showed that STAT3-high enriched for almost equal patient numbers of mesenchymal and classical subtypes in either of glioma or GBM cohort (Gravendeel, Fig. 1b, g; TCGA, Supplementary Fig. 2a, c).